Skip to main content
  • Early Data Suggest ACURATE neo2 Performs Similarly to Contemporary Commercially Available TAVR Valves

    MIAMI BEACH, Fla. – The second-generation ACURATE neo2 transcatheter heart valve (THV) appears to perform at a similar level to other commercially available contemporary THVs, according to European registry data presented Tuesday at Transcatheter Valve Therapies (TVT) 2021.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details